The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Abstract

The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer invasion and metastasis. We here report that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers. Furthermore, we show that those cells have an increased ability to form mammospheres, a property associated with mammary epithelial stem cells. Independent of this, stem cell-like cells isolated from HMLE cultures form mammospheres and express markers similar to those of HMLEs that have undergone an EMT. Moreover, stem-like cells isolated either from mouse or human mammary glands or mammary carcinomas express EMT markers. Finally, transformed human mammary epithelial cells that have undergone an EMT form mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties.

Long non‐coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation

“…Trastuzumab has proven efficacy as first‐line treatment of advanced HER2 + breast cancer patients. However, initial benefit lasts not long before the occurrence of conversion, resulting in an acquired resistance 27. Therefore, breakthroughs were needed in the finding of effective therapeutic targets and overcome of acquired trastuzumab resistance, especially for patients with HER2 + sites.…”

Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells

“…The EMT is a critical regulator of the CSC phenotype, and studies have reported that the EMT can generate tumor cells, and even normal cells, with CSC‐like properties 3, 27, 28. We had proved that FLI‐1 correlates positively with the EMT, and silencing FLI‐1 inhibited the expression of mesenchymal markers.…”

Concise Review: Aggressive Colorectal Cancer: Role of Epithelial Cell Adhesion Molecule in Cancer Stem Cells and Epithelial-to-Mesenchymal Transition

“…CSCs 33, 34, 60 and EMT 35, 37, 42, 43 both fuel cancer progression and mediate drug resistance. The transmembranous glycoprotein EpCAM exerts distinct and partially paradoxical functions in CSCs and EMT: while CSCs from epithelial‐derived tumors express high levels of EpCAM, EMT cells have downregulated the expression of this key epithelial denominator.…”

“…Accumulating evidence suggests a strong and possibly causal link between EMT and the acquisition of stem cell properties in both normal and malignant epithelial cells 42, 43. In addition, EpCAM, along with other markers such as E‐cadherin and cytokeratins, defines a key denominator of the epithelial cell state.…”